The High Cost of New Cancer Therapies-A Challenge of Inequality for All Countries.
作者信息
Røe Oluf Dimitri
机构信息
Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
出版信息
JAMA Oncol. 2017 Sep 1;3(9):1169-1170. doi: 10.1001/jamaoncol.2016.6335.
PMID:28033441
Abstract
摘要
相似文献
1
The High Cost of New Cancer Therapies-A Challenge of Inequality for All Countries.新型癌症治疗的高昂成本——所有国家面临的不平等挑战
JAMA Oncol. 2017 Sep 1;3(9):1169-1170. doi: 10.1001/jamaoncol.2016.6335.
2
Perspectives on Cost and Value in Cancer Care.癌症护理中的成本与价值观点。
JAMA Oncol. 2016 Jan;2(1):19-21. doi: 10.1001/jamaoncol.2015.4191.
3
Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective.扩大全球放疗可及性：欧洲放射治疗与肿瘤学会的观点
Lancet Oncol. 2015 Sep;16(10):1148-9. doi: 10.1016/S1470-2045(15)00288-0.
4
The intersection of global health with cancer control.全球健康与癌症控制的交叉领域。
Lancet Oncol. 2015 Sep;16(10):1143. doi: 10.1016/S1470-2045(15)00297-1.
5
Global Task Force on Radiotherapy for Cancer Control.全球癌症控制放射治疗特别工作组
Lancet Oncol. 2015 Sep;16(10):1144-6. doi: 10.1016/S1470-2045(15)00285-5.
6
The verdict is in: the time for effective solutions to the global cancer burden is now.结论已经明确：现在是找到有效解决全球癌症负担问题办法的时候了。
Lancet Oncol. 2015 Sep;16(10):1146-7. doi: 10.1016/S1470-2045(15)00276-4.
7
Radiotherapy in southeast Asia: room to grow.东南亚的放射治疗：发展空间
Lancet Oncol. 2015 Sep;16(10):1149-50. doi: 10.1016/S1470-2045(15)00291-0.
8
Expanding global access to radiotherapy: the IAEA perspective.扩大全球放疗可及性：国际原子能机构的观点
Lancet Oncol. 2015 Sep;16(10):1151-2. doi: 10.1016/S1470-2045(15)00287-9.
9
Telemedicine health disparities in oncology care.肿瘤护理中的远程医疗健康差异。
Future Oncol. 2021 May;17(14):1695-1698. doi: 10.2217/fon-2021-0022. Epub 2021 Feb 26.
10
Cancer funding in developing countries: the next health-care crisis?发展中国家的癌症资金：下一场医疗危机？
Lancet. 2010 Nov 27;376(9755):1827. doi: 10.1016/S0140-6736(10)62168-X.
引用本文的文献
1
Socioeconomic inequality in health care use among cancer patients in China: Evidence from the China health and retirement longitudinal study.中国癌症患者医疗利用的社会经济不平等：来自中国健康与养老追踪调查的证据。
Front Public Health. 2022 Aug 2;10:942911. doi: 10.3389/fpubh.2022.942911. eCollection 2022.
2
End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study.中国城市癌症患者临终费用及其决定因素：基于人群的回顾性研究。
BMJ Open. 2019 Mar 20;9(3):e026309. doi: 10.1136/bmjopen-2018-026309.
3
Trajectories of Hospitalization Cost Among Patients of End-Stage Lung Cancer: A Retrospective Study in China.终末期肺癌患者住院费用的变化轨迹：中国的一项回顾性研究。
Int J Environ Res Public Health. 2018 Dec 15;15(12):2877. doi: 10.3390/ijerph15122877.
4
Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe₃O₄-PEG-GA) Against Lung, Breast and Colon Cancer Cells.没食子酸的磁铁矿纳米复合制剂（Fe₃O₄-PEG-GA）对肺癌、乳腺癌和结肠癌细胞的抗癌效果增强
Nanomaterials (Basel). 2018 Feb 2;8(2):83. doi: 10.3390/nano8020083.
5
Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.应对精准医学时代高价处方药的挑战：对药物生命周期、治疗药物市场和监管框架的系统评价
PLoS One. 2017 Aug 16;12(8):e0182613. doi: 10.1371/journal.pone.0182613. eCollection 2017.
Zotero 插件